Percutaneous Tibial Nerve Stimulation (PTNS) for the Treatment of Chronic Anal Fissure
1 other identifier
interventional
52
1 country
1
Brief Summary
Chronic anal fissure rarely heals spontaneously. About 50% heal on administration om topical muscle relaxants (e.g. diltiazem) and/or injection of Botulinum toxin, but for the remainder of patients surgery (with lateral internal sphincterotomy or fissurectomy) with subsequent risks of anal incontinence has been the golden standard. Treatment with PTNS (percutaneous tibial nerve stimulation) has been showed to produce healing of chronic anal fissures not responding to topical treatment, thus avoiding the risk for debilitating anal incontinence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 14, 2020
CompletedFirst Posted
Study publicly available on registry
October 27, 2020
CompletedStudy Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
March 1, 2024
February 1, 2024
2.2 years
October 14, 2020
February 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Healing rate
Healing of anal fissure from assessement of clinical and/or data from patient form
3 months after treatment
Healing rate
Healing of anal fissure from assessement of clinical and/or data from patient form
12 months after treatment
Secondary Outcomes (6)
Bowel movements
3 months after treatment
Bowel movements
12 months after treatment
Adverse effects
3 months after treatment
Adverse effects
12 months after treatment
Smoking
3 months after treatment
- +1 more secondary outcomes
Study Arms (1)
PTNS
EXPERIMENTALTreatment with PTNS for chronic anal fissure, treatment to be given for 30 minutes during 10 consecutive work Days.
Interventions
Patients meeting the criteria are treated with PTNS and are evaluated at 3 months and 1 year after end of treatment.
Eligibility Criteria
You may qualify if:
- Verified anal fissure (Clinical assessement by experienced proctological surgeon)
- Full conservative treatment has been given
You may not qualify if:
- Inflammatory bowel disease
- Fistula and/or anal abscess
- Patients with compromised immunity
- Pregnancy
- Treatment with anti-coagulants (not aspirin)
- Previous irradiation towards pelvic floor
- Pacemaker or implanted defibrillator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Skanelead
Study Sites (1)
Skåne University Hospital
Malmo, Sweden
Related Publications (1)
Nelson RL, Thomas K, Morgan J, Jones A. Non surgical therapy for anal fissure. Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD003431. doi: 10.1002/14651858.CD003431.pub3.
PMID: 22336789BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Louis B Johnson, PhD
Lund University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 14, 2020
First Posted
October 27, 2020
Study Start
October 1, 2024
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
March 1, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share
No intention to make individual participant data available to other researchers